Skip to Content

Kuros Biosciences Ltd CSBTF

Morningstar Rating
$6.50 −0.70 (9.72%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CSBTF is trading at a 44% discount.
Price
$6.54
Fair Value
$27.45
Uncertainty
Extreme
1-Star Price
$97.33
5-Star Price
$4.44
Economic Moat
Bqy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CSBTF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$7.20
Day Range
$6.286.50
52-Week Range
$1.897.20
Bid/Ask
$6.16 / $6.80
Market Cap
$238.98 Mil
Volume/Avg
832 / 2,515

Key Statistics

Price/Earnings (Normalized)
Price/Sales
10.49
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
66

Comparables

Valuation

Metric
CSBTF
MOVE
VBSN
Price/Earnings (Normalized)
46.4219.89
Price/Book Value
3.349.111.84
Price/Sales
10.495.621.77
Price/Cash Flow
23.5515.30
Price/Earnings
CSBTF
MOVE
VBSN

Financial Strength

Metric
CSBTF
MOVE
VBSN
Quick Ratio
1.841.084.09
Current Ratio
2.262.575.03
Interest Coverage
−7.789.29
Quick Ratio
CSBTF
MOVE
VBSN

Profitability

Metric
CSBTF
MOVE
VBSN
Return on Assets (Normalized)
−17.92%9.08%7.64%
Return on Equity (Normalized)
−21.70%19.61%9.38%
Return on Invested Capital (Normalized)
−19.98%17.24%9.19%
Return on Assets
CSBTF
MOVE
VBSN
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesRlmyfg$207.3 Bil
SYK
Stryker CorpGnll$135.0 Bil
MDT
Medtronic PLCLlgd$113.9 Bil
BSX
Boston Scientific CorpSpgcf$98.3 Bil
EW
Edwards Lifesciences CorpDtmbw$52.8 Bil
DXCM
DexCom IncDht$44.8 Bil
ZBH
Zimmer Biomet Holdings IncRfzbv$26.5 Bil
ALGN
Align Technology IncJxcvml$24.3 Bil
PHG
Koninklijke Philips NV ADRYbspy$18.3 Bil
PODD
Insulet CorpMjltv$12.9 Bil

Sponsor Center